Tue, Jan 27, 2015, 4:14 AM EST - U.S. Markets open in 5 hrs 16 mins


% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • beachinv beachinv Apr 26, 2013 9:19 AM Flag


    As I said before the stock market is really a function of supply and demand. We can't control how much others want the stock but we can affect the supply as their is a finite quantity of shares available. Hold tight to your shares until you see the full valuation of this drug platform. The manipulators have controlled this stock for last 3 yrs by preying on fears/rumors - this was trading closer to $14 less than 2yrs ago before the BS about safety/clinical hold. We knew that was not true and this has been confirmed with FDA lifting the hold and subsequent dog safety studies. The shorts/funds that wanted to steal shares used these fears to drive the stock even to below $3 last summer. Now we can see how they manipulate stock to their adavntage and get your shares. As for valuation, I think at a minimum this platform should currently be valued closer to $500-$700 MM mkt cap. Once the ph3 clinical trials in CF come out - you will see the validation of the drug platform and analysts and investors look at the mkt for both CF and NTM - then it is my feeling that we will see a rapid increase in valuation $1B plus as there are other applications in pulmonary and other settings using this technology. I have also said that it will be obvious when the institutions come for your shares - like going through eye of needle when shares are not available for sale. I say that we have been screwed for years in the valuation of this company - now that we are closer to catalysts/validation lets turn the tables on the manipulators and make them pay fair value for the shares....=) Apologize in advance for the long msg.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
15.95+1.06(+7.12%)Jan 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQMon, Jan 26, 2015 4:00 PM EST
Microsoft Corporation
NASDAQMon, Jan 26, 2015 4:00 PM EST
NASDAQMon, Jan 26, 2015 4:00 PM EST